| AEGERA THERAPEUTICS, INC. Patent applications |
| Patent application number | Title | Published |
|---|
| 20110177060 | IAP BIR DOMAIN BINDING COMPOUNDS - IAP BIR domain binding compounds of Formula (I), (II), (III), or (IV), and the use thereof, for example, for the treatment or prevention of proliferative diseases. | 07-21-2011 |
| 20110171171 | BRIDGED SECONDARY AMINES AND USE THEREOF AS IAP BIR DOMAIN BINDING COMPOUNDS - A compound of Formula 1.1A: 1.1A or salt thereof, as well as methods of making compounds of Formula 1.1A, methods of using compounds of Formula 1.1A to treat proliferative disorders such as cancer, and related compounds, composition, and methods. | 07-14-2011 |
| 20110117081 | FUNCTIONALIZED PYRROLIDINES AND USE THEREOF AS IAP INHIBITORS - A compound of Formula (1) or a salt thereof, methods for the preparation and use of such a compound, especially as an IAP inhibitor, and related compounds, compositions, and methods. | 05-19-2011 |
| 20100292269 | BIR DOMAIN BINDING COMPOUNDS - The present invention is directed towards an isomer, an enantiomer, a diastereoisomer, or a tautomer of a pyrrolidine compound represented by Formula I: | 11-18-2010 |
| 20100221261 | IAP BIR DOMAIN BINDING COMPOUNDS - Disclosed is an isomer, enantiomer, diastereoisomer or tautomer of a compound represented by Formula I or II | 09-02-2010 |
| 20100203012 | IAP BIR DOMAIN BINDING COMPOUNDS - Disclosed herein is a compound of Formula 1: | 08-12-2010 |
| 20090192140 | IAP BIR DOMAIN BINDING COMPOUNDS - Disclosed herein is an isomer, enantiomer, diastereoisomer or tautomer of a compound represented by Formula I: | 07-30-2009 |
| 20090170845 | USE OF IMIDAZO[2,1-b]-1,3,4-THIADIAZOLE-2-SULFONAMIDE COMPOUNDS TO TREAT NEUROPATHIC PAIN - Disclosed herein are methods and compositions for treating and/or prophylaxis of neuropathic pain in a subject. The methods comprise administering to the subject suffering from neuropathic pain, a therapeutically effective amount of a compound, according to Formula I: | 07-02-2009 |
| 20090042953 | IMIDAZO [2,1,-b]-1,3,4-THIADIAZOLE SULFONAMIDES - This invention relates to compounds of Formula I and the use of compounds of Formula I as neuroprotective agents in the treatment of neuronal disorders of the central and peripheral nervous systems. Formula I: | 02-12-2009 |
